Experience. Commitment. Results.
Argo Group International Holdings, Ltd. (NYSE: ARGO), relating to its proposed sale to Brookfield Reinsurance. Under the terms of the agreement, ARGO shareholders are expected to receive $30.00 in cash per share they own
AlerisLife Inc. (NASDAQ: ALR), relating to its proposed sale to APB Acquisition LLC. Under the terms of the agreement, ALR shareholders are expected to receive $1.31 in cash per share they own.
Chembio Diagnostics, Inc. (NASDAQ: CEMI), relating to its proposed sale to Biosynex SA. Under the terms of the agreement, CEMI shareholders are expected to receive $0.45 in cash per share they own.
Atlas Technical Consultants, Inc. (NASDAQ: ATCX), relating to its proposed sale to GI Partners. Under the terms of the agreement, ATCX shareholders are expected to receive $12.25 in cash per share they own.
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE), relating to its proposed acquisition by Sun Pharmaceutical Industries Limited. Under the terms of the tender offer, CNCE shareholders are expected to receive $8.00 in cash and one non-tradeable CVR worth a deferred $3.50 in cash per share they own.
Leap Therapeutics, Inc. (NASDAQ: LPTX), relating to its proposed purchase of Flame Biosciences, Inc. Under the terms of the agreement, LPTX will issue shares of common stock and Series X non-voting convertible preferred stock to Flame shareholders, with each Series X share convert to 1000 shares of common stock upon approval of the transaction.
Volta Inc. (NYSE: VLTA), relating to its proposed sale to Shell USA. Under the terms of the agreement, VLTA shareholders are expected to receive $0.86 in cash per share they own.
Calyxt, Inc. (NASDAQ: CLXT), relating to its proposed merger with Cibus. Under the terms of the agreement, Cibus shareholders are expected to receive new shares of CLXT, with CLXT shareholders expected to own approximately 5% of the combined company.
Angion Biomedica Corp. (NASDAQ: ANGN), relating to its proposed merger with Elicio Therapeutics. Under the terms of the agreement, Elicio shareholders are expected to receive new shares of ANGN, with ANGN shareholders expected to own approximately 34.5% of the combined company.
Golden Matrix Group, Inc. (NASDAQ: GMGI), relating to its proposed merger with MeridianBet Group.